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Summary
Background Testosterone plays an important role in
the regulation of glucose metabolism. While earlier
studies have shown that it has a protective effect in
males, unfavorable effects of testosterone on glucose
metabolism have been reported in females; however,
whether there is a sex-specific relationship between
testosterone and glucose metabolism in patients with
prediabetes has not been investigated in detail hith-
erto.
Methods This cross-sectional analysis investigated 423
males and 287 females with diagnosed prediabetes.
Detailed assessment of their metabolic profiles was
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performed, including a 2-h oral glucose tolerance test
(OGTT), HbA1c levels, calculation of insulin resistance
with homeostatic model assessment for insulin re-
sistance (HOMA-IR), assessment of lipid metabolism,
anthropometric parameters and the fatty liver index
(FLI). By using Spearman’s correlation test, we inves-
tigated the sex-specific relationship between testos-
terone and metabolism in the prediabetic individuals.
Results In the present study, prediabetic females
(mean age 58.6 years, confidence interval [CI: 57.6y;
59.5y]) were characterized by lower fasting plasma
glucose levels (104.2mg/dl [CI: 103.0mg/dl; 105.4mg/
dl] vs. 106.9mg/dl [CI: 106.0mg/dl; 107.8mg/dl])
and a lower FLI (49.5 [CI: 45.7; 53.2] vs. 58.8 [CI:
55.8; 61.8]), but presented with a higher risk of devel-
oping manifest type 2 diabetes in the next 10 years
(FINDRISK score: 17.6 [CI: 17.1; 18.1] vs. 16.1 [CI: 15.7;
16.5]) when compared to prediabetic males (mean
age: 58.04years [CI: 57.0y; 59.1y]). Testosterone was
negatively related to insulin resistance (HOMA-IR:
Spearman’s ρ: –0.33, p< 0.01), 2-h stimulated glucose
levels during the OGTT (ρ= –0.18, p<0.01), HbA1c
levels (ρ= –0.13, p<0.05), FLI and BMI in prediabetic
males; however, no relationship between testosterone
and metabolic parameters could be found in predia-
betic females.
Conclusion The increase of testosterone levels in
males was related to amore favorable glucosemetabo-
lism, including lower HbA1c, lower stimulated glu-
cose levels and higher insulin sensitivity; however, in
prediabetic females, testosterone was not related to
glucose metabolism.
Keywords Prediabetes · Testosterone · Insulin
resistance · Fatty liver · Sex-specific differences
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Introduction
In recent years, the prevalence of type 2 diabetes mel-
litus (T2DM) has been steadily increasing and is pre-
dicted to rise even further worldwide by 2045. Latest
numbers from the International Diabetes Federation
demonstrate that 9.3% of the world’s population have
T2DM [1]. Physiologically, sex hormones are involved
in the regulation of glucose metabolism and are es-
sential for maintenance of glucose homeostasis [2]. In
men, testosterone is linked to insulin sensitivity and
glycemic control [3]. Accordingly, in males there is
a correlation between testosterone deficiency and the
prevalence of prediabetes [4] and insulin resistance
[5], meaning testosterone has favorable effects on glu-
cose metabolism in males. Furthermore, low testos-
terone and sex hormone binding globulin (SHBG)
levels in men can be linked to increased visceral fat
content [6]. Conversely, higher testosterone levels and
testosterone replacement therapy show beneficial ef-
fects on glucose homeostasis in men [7]; however,
this does not seem to apply to women, since high
testosterone blood levels in women are associated
with T2DM [2, 3] and have been linked to diseases
such as polycystic ovary syndrome [8]. Interestingly,
there are sex-specific differences in the diagnosis of
disturbances in glucose metabolism between men
and women. Men more often suffer from increased
fasting plasma glucose levels (FPG), whereas women
more often suffer from impaired glucose tolerance,
which is diagnosed with the oral glucose tolerance
test (OGTT). The pathophysiological mechanisms
behind these sex-specific differences are not entirely
clear to date; however, one of the main reasons for
the higher occurrence of increased FPG levels in men
may be the elevated hepatic glucose output as well
as impaired early insulin secretion. On the other
hand, women more often suffer from impaired glu-
cose tolerance (IGT) and an explanation for these
sex-specific differences may be the slower duration of
gastric emptying and intestinal glucose absorption in
women [9]; however, especially the influence of sex
hormones on disturbances of glucose metabolism in
prediabetic patients is, overall, an unexplored area.
Hence this study aimed to investigate the relation-
ship between testosterone and glucose metabolism in
prediabetic patients in a sex-specific manner.
Methods
Study design and methods
The cross-sectional study at hand (ethics approval
from the Medical University of Vienna, 1089/2017) is
a retrospective data analysis with an explorative char-
acter of first visits to the prediabetes clinic at “Health
and Prevention Center KFA” in Vienna from Octo-
ber 2015 to September 2017. As part of a standard
medical check-up, patients underwent a thorough
physical examination, electrocardiogram, extensive
blood analysis and assessment of vital parameters.
Patients were classified as prediabetic patients ac-
cording to the guidelines of the American Diabetes
Association (ADA) if HbA1c was ≥5.7% and <6.5%
and/or if they had fasting blood glucose levels of
≥100mg/dl and <126mg/dl and/or ≥140mg/dl and
<200mg/dl in a 2-h OGTT. All patients gave written
informed consent. Patients suffering from chronic or
acute infections, severe endocrine diseases (such as
Cushing’s disease), known hepatitis infection, HIV,
present malignant diseases, systemic cortisone treat-
ment, or testosterone substitution were excluded from
the analysis.
Calculations
We calculated the homeostasis model assessment in-
sulin resistance score (HOMA-IR) using basal insulin
and glucose levels (HOMA-IR= Ins×Gluc/405), the
fatty liver index (FLI) and the Finnish diabetes risk
score (FINDRISK score) [10, 11].
Statistical analysis
Descriptive data analysis was performed for all pa-
rameters. Continuous variables were summarized by
mean and confidence intervals. Assumption of Gaus-
sian distribution of parameters was decided by visual
assessment of histograms and quantile-quantile plots
(QQ plots). For normal distributed variables, a two-
sided t-test was used to assess differences between
the two groups, and a Mann-Whitney U test was used
for non-parametrically distributed variables. Due to
the heterogeneous/skeweddistribution of the individ-
ual variables, the Spearman correlation test was used
for all groups to ensure reliable, comparable results.
The statistical analysis was performed using the open
source statistical analysis software R (version 4.01).
Results
Baseline characteristics
Table 1 shows the sex-specific comparison of the
baseline characteristics between prediabetic men and
women. In this analysis (f: 58.6 [CI: 57.6; 59.5] vs.
m: 58.0 [CI: 57.0; 59.1] years), prediabetic males
were characterized by lower total cholesterol and
HDL cholesterol levels when compared to prediabetic
females. The amount of visceral fat in the liver, mea-
sured with the fatty liver index, was significantly lower
in prediabetic females.
However, while investigating glucose metabolism,
we found a significantly higher FINDRISK score in
prediabetic females, which means that they are at
higher risk of developing manifest diabetes in the next
10 years. In general, prediabetic females presented
with lower fasting plasma glucose (FPG); however, no
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Table 1 Baseline characteristics of prediabetic females and males
Males Females
Variable N Mean 95%CI N Mean 95%CI p-value
Age (years) 423 58.0 (57.0; 59.1) 287 58.6 (57.6; 59.5) 0.48
BMI (kg/m2) 419 28.2 (27.6; 28.7) 284 28.3 (27.7; 28.9) 0.87
Cholesterol (mg/dl) 415 205.6 (201.8; 209.5) 278 218.9 (214.4; 223.4) <0.01
HDL cholesterol (mg/dl) 416 56.2 (54.8; 57.7) 279 65.9 (64.0; 67.8) <0.01
LDL cholesterol (mg/dl) 413 125.9 (122.4; 129.4) 279 130.8 (126.6; 34.9) 0.08
Triglycerides (mg/dl) 416 115.7 (109.4; 121.9) 279 110.2 (104.6; 115.8) 0.88
Fatty liver Index 294 58.8 (55.8; 61.8) 197 49.5 (45.7; 53.2) <0.01
Find risk score 299 16.1 (15.7; 16.5) 196 17.6 (17.1; 18.1) <0.01
Glucose (mg/dl) 402 106.9 (106.0; 107.8) 267 104.2 (103.0; 105.4) <0.01
Insulin (µU/ml) 279 12.6 (11.6; 13.6) 181 13.1 (12.1; 14.1) 0.07
HOMA-IR 197 3.5 (3.2; 3.8) 134 3.4 (3.1; 3.8) 0.84
Glucose levels (mg/dl)—OGTT 2h 289 117.4 (113.8; 121.0) 196 119.8 (115.3; 124.3) 0.41
Fasting glucose levels (mg/dl)—OGTT 291 108.5 (107.5; 109.4) 196 106.7 (105.4; 108.0) 0.03
Testosterone (ng/ml) 284 4.5 (4.3; 4.7) 176 0.2 (0.2; 0.2) <0.01
Vitamin D (ng/ml) 404 27.2 (26.1–28.2) 270 29.6 (28.1–31.2) 0.02
HbA1c>5.7%—≤6.5% 131 5.9 (5.8; 5.9) 134 5.9 (5.9; 5.9) 0.22
Fasting glucose 100–<126mg/dl 252 109.2 (108.0; 110.0) 147 109.0 (108.0; 110.1) 0.53
Glucose levels 140–<200mg/dl after 2h during the OGTT (mg/dl) 69 159.8 (156.2; 163.5) 42 162.6 (157.6; 167.7) 0.42
BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, HOMA-IR homeostatic model assessment for insulin resistance, OGTT oral glu-
cose tolerance test
Table 2 Sex-specific correlation analysis of testosterone
with metabolic parameters
Males Females
Variable N ρ p-value N ρ p-value
Fasting glucose levels
(mg/dl)—OGTT
276 –0.06 0.35 174 –0.02 0.80
Glucose levels
(mg/dl)—OGTT 2h
274 –0.18 <0.01 174 –0.05 0.53
HbA1c (%) 270 –0.13 0.04 170 0.00 0.99
HOMA-IR 195 –0.33 <0.01 131 –0.08 0.38
Fatty liver index 275 –0.36 <0.01 171 0.08 0.31
BMI (kg/m2) 284 –0.31 <0.01 174 0.04 0.63
Cholesterol (mg/dl) 282 0.03 0.61 171 0.04 0.62
HDL cholesterol (mg/dl) 283 0.19 <0.01 172 –0.10 0.18
LDL cholesterol (mg/dl) 281 0.07 0.28 172 0.05 0.52
Triglycerides (mg/dl) 282 –0.18 <0.01 172 –0.02 0.81
OGTT oral glucose tolerance test, 2h 2 hours, HOMA-IR homeostatic model
assessment for insulin resistance, BMI body mass index, HDL high-density
lipoprotein, LDL low-density lipoprotein
sex-specific differences could be found for the stimu-
lated glucose levels during the OGTT after 2h, HbA1c
levels or the HOMA-IR.
Correlation analyses of testosterone with metabolic
parameters
In a sex-specific correlation analysis (Table 2) our
results show that there is a significant relationship be-
tween testosterone and glucose and lipid metabolism
and between testosterone and anthropometric pa-
rameters in prediabetic males. The higher the levels
of testosterone, the lower the levels of HbA1c and
the lower the grade of insulin resistance measured
with the HOMA index (Fig. 1) were in prediabetic
males. Additionally, there was a negative relation-
ship between testosterone and the stimulated glucose
levels after 2h in the OGTT in males (Fig. 1). We
could also observe a favorable relationship between
testosterone and the visceral fat content in the liver
and anthropometric parameters (including FLI and
BMI) in prediabetic males. Additionally, there was
also a favorable relationship between testosterone
and lipid parameters in prediabetic males, includ-
ing a positive relationship with HDL cholesterol and
a negative relationship with triglycerides; however,
we could not find a relationship between testosterone
and metabolic parameters in prediabetic females.
Discussion
The present study aimed to examine the sex-spe-
cific relationship between testosterone and glucose
metabolism in prediabetic men and women. Pre-
diabetic females were characterized by lower FPG
levels and a lower FLI but had a higher risk of de-
veloping manifest diabetes in the next 10 years when
compared to prediabetic men. Interestingly, testos-
terone seemed to have an overall favorable effect
on metabolic profiles in prediabetic males, showing
that there was a negative relationship with insulin
resistance, HbA1c, stimulated glucose levels during
the OGTT, FLI and BMI. Additionally, the increase
in testosterone was related to a more favorable lipid
profile in prediabetic men; however, in females we
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Fig. 1 Correlation be-
tween testosterone and
a insulin resistance and
b stimulated glucose lev-
els in males. The linear re-
lationship is indicated by
the blue regression line with
the corresponding standard
error (gray error bar). The
confidence lines for the pre-
dicted values are indicated
by a red dotted line
could not find a relationship between testosterone
and metabolic parameters.
Although there is an abundance of available data
showing an effect of testosterone on glucose metabo-
lism in general or, more specifically, T2DM, there is
only a limited amount of information on the influence
of testosterone in the prediabetic state; however, ex-
isting data clearly indicate that prediabetic men show
decreased testosterone or SHBG levels [12, 13]. In
males, decreased testosterone levels are related to the
development of disturbances in glucose metabolism,
including increased risk of developing diabetes, and
also showed a relationship with increased all-cause
and cardiovascular mortality risk [6] as well as greater
risk of developing a metabolic syndrome [14]. The
significant role of testosterone in glucose metabolism
in males is also reflected in the higher likelihood of
lowered testosterone levels in T2DM patients com-
pared to non-diabetics [15]. So far, it is not entirely
known whether decreased levels of testosterone are
the causal factor for metabolic derailment [9]. Nev-
ertheless, one has to keep in mind that testosterone
replacement therapy in hypogonadal diabetic males is
related to an improvement of insulin sensitivity in pa-
tients with T2DM, metabolic syndrome or both [16].
Additionally, in patients receiving an androgen-lower-
ing therapeutic regimen for the treatment of prostate
cancer, the amount of visceral fat and insulin resis-
tance increases under this therapy [15]. Furthermore,
the detrimental effects androgen deficiency exerts on
glucose homeostasis were also demonstrated in ani-
mal studies and cell culture experiments in which in-
sulin secretion was impaired on top of testosterone
deprivation [17]. Notably, there seems to be a bidirec-
tional relationship between plasma testosterone and
the integrity of glucose homeostasis. On the one hand,
hyperglycemia suppresses gonadal testosterone pro-
duction [18], while on the other hand testosterone
deficiency leads to decreased muscle mass [19] and
hence reduced glucose uptake in muscle [20]. Strik-
ingly, in a prediabetic population, testosterone treat-
ment showed a reduction in waist circumference and
body weight, as well as an improvement in HbA1c and
FPG—in comparison, 40% of the prediabetic partici-
pants in the control group progressed to T2DM [21].
Interestingly, the effect of testosterone on the glucose
metabolism seems to play a central role in the de-
velopment of prediabetes. In a prospective clinical
study, Minooee et al. detected that low testosterone
levels were related to the development of prediabetes
but could not find a relationship between the con-
version of prediabetes to T2DM [22]. In the present
study, we could show that especially in prediabetic
men there is a significant relationship between testos-
terone and metabolic profiles. Increases in testos-
terone were related to a lower FLI, better insulin sen-
sitivity, lower HbA1c and lower stimulated glucose
levels, which are all markers directly related to the
development of T2DM. One possible explanation for
improved peripheral insulin sensitivity when testos-
terone levels are higher is the facilitation of glucose
transporter type 4 (GLUT4) translocation to the my-
ocytal membrane and, consequently, greater capac-
ity for peripheral glucose uptake [20]. Furthermore,
the protective effect testosterone exerts on peripheral
glucose tolerance seems to be robust when correcting
for age. Unlike in males, negative effects of testos-
terone on glucose metabolism have been reported in
women [9]. For instance, elevated testosterone lev-
els have been demonstrated in women with diabetes
[23]—a constellation also typically present in polycys-
tic ovary syndrome [24–26]. The role of testosterone
in the prediabetic state in females is, overall, an unex-
plored area. Based on earlier results [9, 23], expecta-
tion of a negative effect of testosterone on the glucose
metabolism in prediabetic females was high; however,
in the present study we could not find a relationship
between testosterone and insulin resistance, HbA1c,
stimulated glucose levels during the OGTT or under
fasting conditions and FLI or anthropometric param-
eters in prediabetic female subjects.
The role of testosterone in the sex-specific di-
agnostic differences in the disturbances of glucose
metabolism is particularly interesting and our re-
sults provide more detailed knowledge on this topic.
In general, males suffer more often from impaired
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fasting glucose levels driven by increased hepatic
glucose output and dysfunctional early insulin se-
cretion, whereas in females a higher occurrence of
impaired glucose tolerance (IGT), mediated via pe-
ripheral insulin resistance, has been observed [9].
Interestingly, our results showing that there is a nega-
tive relationship between testosterone and stimulated
glucose levels in prediabetic males demonstrate that
testosterone could be an additional reason for the
lower occurrence of IGT in males. As a possible
mechanism, Navarro et al. showed that testosterone
amplifies the effect of glucagon-like peptide 1 (GLP-
1) and enhances beta-cell function [27].
Finally, our results showing that testosterone seems
to have favorable effects on the lipid profile in males
are in line with earlier studies [6, 21].
Our study has limitations which have to be re-
ported. Firstly, the present study has a cross-sectional
study design and thus, we assessed correlations but
not causal relationships. Secondly, we did not mea-
sure the levels of estrogen as well as the visceral fat
content in the liver using gold standard methods such
as magnetic resonance spectroscopy or ultrasound.
Furthermore, we only assessed bivariate correlations
between testosterone and metabolic parameters and
therefore cannot rule out that the correlation in fe-
males is masked by a correlation with unobserved
confounders; however, we noted that both males
and females had comparable distributions of age and
BMI. We had a smaller sample of females than males,
which renders significant results in females less likely;
however, males not only had lower p-values but also
had slightly higher correlation coefficients.
In conclusion, our results show that there is a weak
favorable relationship between testosterone and both
glucose and lipid metabolism as well as with the vis-
ceral fat content in the liver, measured by FLI in pre-
diabetic males. Interestingly, testosterone was not re-
lated to the metabolic profile in prediabetic females.
Large prospective clinical studies are needed in order
to investigate the sex-specific role of testosterone on
metabolic profiles in more detail.
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